Gareb, B.; Posthumus, S.; Beugeling, M.; Koopmans, P.; Touw, D.J.; Dijkstra, G.; Kosterink, J.G.W.; Frijlink, H.W.
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process. Pharmaceutics 2019, 11, 428.
https://doi.org/10.3390/pharmaceutics11090428
AMA Style
Gareb B, Posthumus S, Beugeling M, Koopmans P, Touw DJ, Dijkstra G, Kosterink JGW, Frijlink HW.
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process. Pharmaceutics. 2019; 11(9):428.
https://doi.org/10.3390/pharmaceutics11090428
Chicago/Turabian Style
Gareb, Bahez, Silke Posthumus, Max Beugeling, Pauline Koopmans, Daan J. Touw, Gerard Dijkstra, Jos G.W. Kosterink, and Henderik W. Frijlink.
2019. "Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process" Pharmaceutics 11, no. 9: 428.
https://doi.org/10.3390/pharmaceutics11090428
APA Style
Gareb, B., Posthumus, S., Beugeling, M., Koopmans, P., Touw, D. J., Dijkstra, G., Kosterink, J. G. W., & Frijlink, H. W.
(2019). Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process. Pharmaceutics, 11(9), 428.
https://doi.org/10.3390/pharmaceutics11090428
